Two-thirds of people with post-COVID-19 syndrome have persistent, objective symptoms – including reduced physical exercise capacity and reduced cognitive test performances – for a year or more, with ...

We thank our colleagues for their interest in our Article.1 In response to Ari R Joffe, we provided estimates of the number of severe outcomes associated with a fully vaccinated counterfactual. These ...

In their Article, the HDR UK COALESCE Consortium concluded that those who are fully vaccinated against SARS-CoV-2 are less likely to be admitted to hospital and to die with COVID-19.1 If the tests for ...

Researchers from the Massachusetts Institute of Technology (MIT) and the California Institute of Technology (Caltech) have made significant strides in vaccine development that could protect against ...

Although numerous studies have shown men have more severe acute COVID cases and higher mortality than women, females in their 40s have up to a 45% higher risk of getting long COVID than men, according ...

A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.

MultiCare Health System announced all of its regions, including the Inland Northwest, will require masks for patients, visitors and staff in all patient care areas.

MIT and Caltech scientists designed a new vaccine targeting stable virus regions to protect against various coronavirus strains.

A study of nearly 1,000 people with post-COVID-19 syndrome (PCS) revealed that two-thirds still experienced significant symptoms, including reduced exercise capacity and cognitive performance, two ...

The predominant symptom clusters among people with PCS were fatigue/exhaustion, neurocognitive disturbances, chest symptoms/breathlessness, and anxiety/depression/sleep problems. Nearly 68% of people ...

Roche has obtained U.S. government green lights allowing its point-of-care testing system to be used to screen for multiple sexually transmitted infections from a single sample. | The company’s cobas ...